Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
marianna.nuti@uniroma1.it
Marianna Nuti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
marianna.nuti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: Systematic review and Meta-Analysis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile
BIOMEDICINES
2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
FRONTIERS IN IMMUNOLOGY
2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients
ANNALS OF ONCOLOGY
2022
CD137+ T-Cells: Protagonists of the immunotherapy revolution
CANCERS
2021
Rheumatoid factor: A novel determiner in cancer history
CANCERS
2021
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study
JOURNAL OF PERSONALIZED MEDICINE
2021
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis
FRONTIERS IN IMMUNOLOGY
2021
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice
FRONTIERS IN ONCOLOGY
2021
Immunogenic cell death and immunomodulatory effects of cabozantinib
FRONTIERS IN ONCOLOGY
2021
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
JOURNAL OF TRANSLATIONAL MEDICINE
2020
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring
JOURNAL OF IMMUNOLOGY RESEARCH
2020
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL
VACCINES
2020
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy
VACCINES
2020
Incorporating parp-inhibitors in primary and recurrent ovarian cancer. A meta-analysis of 12 phase II/III randomized controlled trials
CANCER TREATMENT REVIEWS
2020
The 5-Ws of immunotherapy in head and neck cancer
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
FRONTIERS IN IMMUNOLOGY
2020
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma
JOURNAL OF PERSONALIZED MEDICINE
2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma
CANCERS
2020
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL)
CANCERS
2020
« first
< previous
1
2
3
4
next >
last »
ERC
LS2_15
LS4_6
LS4_12
LS6
LS6_3
LS6_10
LS7_2
KET
Life-science technologies & biotechnologies
Interessi di ricerca
Keywords
tumor immunology
precision medicine
anticancer immunotherapy
Cancer vaccines
Progetti di Ricerca
Immunomonitoring in patients affected by metastatic clear cell renal carcinoma in treatment with Tyrosine-kinase inhibitors and immune check point inhibitors
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma